|
Volumn 30, Issue 1, 2009, Pages 11-18
|
Management of HCV infection: current issues and future options.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
ANTIVIRUS AGENT;
IMMUNOLOGIC FACTOR;
MACROGOL DERIVATIVE;
PEGINTERFERON ALFA-2A;
PEGINTERFERON ALFA-2B;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
ANIMAL;
DRUG COMBINATION;
HEPATITIS C;
HUMAN;
LIVER FAILURE;
MICROBIOLOGY;
RECURRENT DISEASE;
REVIEW;
TREATMENT OUTCOME;
ANIMALS;
ANTIVIRAL AGENTS;
DRUG THERAPY, COMBINATION;
HEPATITIS C;
HUMANS;
IMMUNOLOGIC FACTORS;
INTERFERON ALFA-2A;
INTERFERON ALFA-2B;
LIVER FAILURE;
POLYETHYLENE GLYCOLS;
RECURRENCE;
TREATMENT OUTCOME;
|
EID: 68849097704
PISSN: 0250636X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (10)
|
References (65)
|